| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 70.1 | 66.0 | 79.7 |
| Other income | 0.1 | 1.3 | 0.0 |
| Total income | 70.2 | 67.3 | 79.8 |
| Profit before exceptional items & tax | -6.4 | -13.0 | 2.9 |
| Exceptional items | 0.0 | -5.3 | 0.0 |
| Profit before tax | -6.4 | -18.3 | 2.9 |
| Net profit | -2.1 | -15.7 | 0.4 |
| Operating margin | -9.1% | -27.2% | 3.6% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Revenue, year on year | -12.00% |
|---|---|
| Operating profit, year on year | -324.10% |
| Operating profit, quarter on quarter | +54.50% |
NSE results filing, NSE: VIRINCHI. Figures extracted from the filing.
Virinchi Ltd: key numbers
- Share price
- ₹13.04
- Market cap
- ₹147.0 Cr
- Revenue (annual)
- ₹284.4 Cr
- Net profit (annual)
- ₹-26.12 Cr
- P/E (TTM)
- -5.6×Sector 21.8×
- Promoter holding
- 39.46%-0.64% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Virinchi Ltd
All →Virinchi Other Announcement
Virinchi Ltd has dispatched letters to shareholders with the weblink for the Annual Report for FY 2025-26, in compliance with SEBI Listing Regulations.
Virinchi Annual General Meeting
Virinchi Limited has issued a notice for its 37th Annual General Meeting, scheduled for September 30, 2026, to be conducted via video conferencing.
Virinchi Annual Report
Virinchi Ltd submitted its Annual Report and notice for the 37th AGM scheduled on September 30, 2026, to the stock exchanges.
Virinchi Board Meeting Outcome
Virinchi Ltd announced the outcome of its board meeting, including the date for its 37th Annual General Meeting and the reappointment of a director.
Virinchi Annual General Meeting
Virinchi Ltd announced voting results for a postal ballot approving the acquisition of a healthcare business division from its subsidiary, Virinchi Health Care Private Limited.
Virinchi Merger & Restructuring
Virinchi Ltd shareholders approved the slump sale acquisition of the Bristlecone Hospitals business division from its material subsidiary, Virinchi Health Care Private Limited, via postal ballot.